Clinical Trial Update: Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris [Phase 2]

View source ↗

Summary

Phase 2 trial update assessing the efficacy, safety, and tolerability of S6G5T-1 and S6G5T-3 for acne vulgaris has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acne Vulgaris

Drugs mentioned

• S6G5T-1
• S6G5T-3

Snippet

Sponsor: Sol-Gel Technologies, Ltd. | Conditions: Acne Vulgaris | Phase 2 | Status: COMPLETED